Pharmaceutical and life sciences

Helping clients better compete in an evolving health market and improve cost-efficiency and profitability

Top health industry issues of 2019: The New Health Economy comes of age

The US health industry has often lagged other industries when it comes to modernizing. Once thought to operate outside the greater US economy, the industry—with its byzantine payment system, complicated regulatory barriers and reliance on face-to-face interactions—is being disrupted. Finally, there’s robust evidence that what PwC calls the New Health Economy is kicking into gear.

Learn more

The potential impact of tax reform on pharmaceutical and life sciences companies 

From President Trump's tax plan to healthcare reform—we break down developments from Washington and what companies in our industry need to do to anticipate and prepare for legislative change.

Learn more

{{filterContent.facetedTitle}}

Contact us

Karen C. Young
US Pharmaceutical and Life Sciences Leader, PwC US
Tel: +1 (973) 236 5648
Email

Michael Swanick
Global Pharmaceutical and Life Sciences Leader, PwC US
Tel: +1 (267) 330 6060
Email

Kathleen Michael
US Health Industries Tax Leader, PwC US
Tel: +1 (973) 236 4210
Email

Douglas Strang
Global Pharmaceutical and Life Sciences Advisory Leader, PwC US
Tel: +1 (267) 330 3045
Email

Rick Edmunds
Principal, Strategy&, PwC US
Tel: +1 (703) 682 5755
Email

Glenn Hunzinger
US Pharmaceutical and Life Sciences Deals Leader, PwC US
Tel: +1 (646) 818 7742
Email

Laura Robinette
US Pharmaceutical & Life Sciences Assurance Leader, PwC US
Tel: +1 (919) 791 4100
Email

Craig Cleaver
US Pharmaceutical and Life Sciences Risk Assurance Leader, PwC US
Tel: +1 (267) 330 2908
Email

Follow us